TrialX
Image

Remote Ischemic Conditioning to Enhance Resuscitation (RICE) Pilot

Remote Ischemic Conditioning to Enhance Resuscitation (RICE) Pilot

Recruiting
18 years and older
All
Phase 1

Overview

Following resuscitation from out-of-hospital cardiac arrest (OHCA), reperfusion injury can cause cell damage in the heart and brain. Remote ischemic conditioning (RIC) consists of intermittent application of a device such as a blood pressure cuff to a limb to induce non-lethal ischemia. Studies in animals with cardiac arrest as well as in humans with acute myocardial infarction suggest that RIC before or after restoration of blood flow may reduce injury to the heart and improve outcomes but this has not been proven in humans who have had OHCA. The RICE pilot study is a single-center study to assess the feasibility of application of RIC in the emergency department setting for patients transported to the hospital after resuscitation from OHCA.

Eligibility

Included will be those with:

  1. Age 18 years or more;
  2. Defibrillation by laypersons or defibrillation and/or chest compressions by EMS providers dispatched to the scene;
  3. Non-traumatic etiology of arrest, defined as without concomitant blunt, penetrating, or burn-related injury, or uncontrolled bleeding or exsanguination;
  4. Spontaneous circulation upon emergency department arrival;
  5. No response to verbal commands; and
  6. Ongoing or planned induced hypothermia.

Excluded will be those with:

  1. STEMI indicated on first 12-lead ECG obtained after restoration of circulation, defined as ST-elevation of 2 mm in two or more contiguous ECG leads;
  2. Written do not attempt resuscitation (DNAR) reported to providers before randomization;
  3. Drowning or hypothermia as cause of arrest;
  4. Known prisoner or pregnant; or
  5. Dialysis fistula in either upper extremity; or
  6. Pre-existing amputation of upper extremity.

Study details
    Heart disease
    Heart disease
    Cardiac Arrest

NCT04265807

University of Washington

16 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.